Another trial for the TARGET trial. Author's reply.
作者信息
Hagel Stefan, Pletz Mathias W, Lehmann Thomas
机构信息
Institute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.
Center for Sepsis Control and Care (CSCC), Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.
出版信息
Intensive Care Med. 2022 Jun;48(6):776-777. doi: 10.1007/s00134-022-06670-9. Epub 2022 Mar 23.
Abstract
摘要
相似文献
1
Another trial for the TARGET trial. Author's reply.针对TARGET试验的另一项试验。作者回复。
Intensive Care Med. 2022 Jun;48(6):776-777. doi: 10.1007/s00134-022-06670-9. Epub 2022 Mar 23.
2
Author's reply to Wendling and Prati: "treat-to-target in spondyloarthritis: implications for clinical trial designs".作者对温德林和普拉蒂的回复：“脊柱关节炎的治疗达标：对临床试验设计的影响”
Drugs. 2014 Sep;74(14):1717-8. doi: 10.1007/s40265-014-0289-2.
3
Analysis of the MAVIDOS trial - Author's reply.MAVIDOS试验分析——作者回复
Lancet Diabetes Endocrinol. 2017 May;5(5):328-329. doi: 10.1016/S2213-8587(17)30113-4.
4
The MATRIX trial - Author's reply.MATRIX试验——作者回复
Lancet. 2019 May 4;393(10183):1803-1804. doi: 10.1016/S0140-6736(19)30049-2.
5
Methods and outcome reporting in the PACE trial--Author's reply.“慢性疲劳综合征/肌痛性脑脊髓炎的临床评估与管理（PACE）试验”中的方法与结果报告——作者回复
Lancet Psychiatry. 2015 Apr;2(4):e10-1. doi: 10.1016/S2215-0366(15)00114-5. Epub 2015 Mar 31.
6
Unanswered questions from the Evoke trial - Author's reply.关于“唤起”试验的未解答问题——作者回复
Lancet Neurol. 2020 May;19(5):380-381. doi: 10.1016/S1474-4422(20)30111-3.
7
Author's reply to correspondence 'influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation'.作者对信件《关于AYUSH - 64的流感样疾病相关临床试验需谨慎解读》的回复。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100487. doi: 10.1016/j.jaim.2021.07.003. Epub 2021 Dec 27.
8
Key points to consider in the IMPERIAL trial - Author's reply.IMPERIAL试验中需考虑的关键点——作者回复
Lancet. 2019 Jun 22;393(10190):2490. doi: 10.1016/S0140-6736(19)30694-4.
9
Author's reply: Intrapartum management of trial of labour after caesarean delivery: evidence and experience.作者回复：剖宫产术后阴道试产的产时管理：证据与经验
BJOG. 2014 Jun;121(7):911-2. doi: 10.1111/1471-0528.12587.
10
Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial: Author's Reply.呋塞米预防危重症儿童急性肾损伤的试验：一项双盲、随机、对照试验：作者回复
Indian J Pediatr. 2022 May;89(5):527. doi: 10.1007/s12098-022-04100-8. Epub 2022 Mar 23.
引用本文的文献
1
Is therapeutic drug monitoring really helpful for managing piperacillin/tazobactam therapy in critically ill patients?治疗药物监测对危重症患者哌拉西林/他唑巴坦治疗的管理真的有帮助吗？
Intensive Care Med. 2022 Nov;48(11):1676-1678. doi: 10.1007/s00134-022-06830-x. Epub 2022 Aug 9.
2
Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author's reply.关于脓毒症患者治疗药物监测指导下哌拉西林/他唑巴坦治疗的研究设计问题及额外分析建议。作者回复。
Intensive Care Med. 2022 Jun;48(6):772-773. doi: 10.1007/s00134-022-06669-2. Epub 2022 Mar 15.
3
Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis.关于脓毒症患者治疗药物监测指导下哌拉西林/他唑巴坦治疗的研究设计问题及进一步分析建议
Intensive Care Med. 2022 Jun;48(6):770-771. doi: 10.1007/s00134-022-06648-7. Epub 2022 Feb 18.
本文引用的文献
1
Another trial for the TARGET trial.另一项针对TARGET试验的试验。
Intensive Care Med. 2022 Jun;48(6):774-775. doi: 10.1007/s00134-022-06654-9. Epub 2022 Mar 1.
Zotero 插件